Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Primary Care

News · August 14, 2021

mRNA-1273 SARS-CoV-2 Vaccine Seems Safe for Adolescents

Interim analysis shows immune response in adolescents aged 12 to 17 years noninferior to that in young adults aged 18 to 25 years



Further Reading